F-star Therapeutics - Ownership and Business Overview

Life ScienceCompany

F-star Therapeutics Ownership

Who owns F-star Therapeutics?

F-star Therapeutics is owned by InvoX Pharma. It was acquired on June 23, 2022.

F-star Therapeutics Business Overview

Where is F-star Therapeutics headquartered?

F-star Therapeutics is headquartered in Cambridge, United Kingdom.

What is F-star Therapeutics’ revenue?

F-star Therapeutics disclosed revenue of 21M USD for 2021 and 11M USD for 2020.

How many employees does F-star Therapeutics have?

F-star Therapeutics has 84 employees.

What sector is F-star Therapeutics in?

F-star Therapeutics is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Subscribe to Mergr to view all 299 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 262 by strategics.

F-star Therapeutics

F-star Therapeutics, Inc.

Eddeva B920 Babraham Research Campus,
Cambridge, CB22 3AT
United Kingdom,
44 1223 497400
www.f-star.com

F-star Therapeutics is a clinical-stage biopharmaceutical company pioneering bispecifics in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases, through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star Therapeutics is based in Cambridge, United Kingdom.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for F-star Therapeutics

Life Science Companies